Caxton Associates (New York)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Caxton Associates (New York)’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,492	Closed	-$426K	–	630
2023 Q2	$426K	Buy	+1,492	New	+$414K	0.06%	291
2022 Q1	–	Sell	-4,845	Closed	-$864K	–	753
2021 Q4	$864K	Buy	4,845 +141	+3%	+$27.8K	0.09%	145
2021 Q3	$968K	Sell	4,704 -347	-7%	-$68.1K	0.11%	103
2021 Q2	$958K	Buy	5,051 +2,145	+74%	+$351K	0.11%	77
2021 Q1	$379K	Buy	+2,906	New	+$349K	0.03%	217

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Caxton Associates (New York)'s SWAV Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 1,492 shares — an estimated $426K sold.

Caxton Associates (New York) first reported a position in SWAV in Q1 2021 and held it in 5 quarters. The position peaked at $968K in Q3 2021. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

Caxton Associates (New York) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Caxton Associates (New York) sold 1,492 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $426K.
Caxton Associates (New York) first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Caxton Associates (New York)'s Shockwave Medical, Inc. Common Stock position peaked at $968K in Q3 2021.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.